Calypso Biotech
Latest round
- Series A
Last raised
- Sep 2021
Total raised
- $35M
Investors
- 5
About Calypso Biotech
D., Calypso Biotech BV operates as a provider of monoclonal antibodies for treating immune-related diseases to healthcare providers and medical researchers. In January 2024, Novartis International AG agreed to acquire Calypso Biotech BV from Gilde Healthcare Partners, Merck Ventures, Inkef, Johnson & Johnson Innovation, and Fountain Healthcare Partners for USD 250 million, including an additional USD 175 million on achievement of certain milestones. The company provides a wide range of biotech products, such as therapeutic antibodies like CALY-002 for treating conditions such as celiac disease and eosinophilic esophagitis. CALY-002 is a clinical-stage antibody that neutralizes interleukin-15, targeting immune pathologies with large unmet medical needs. Additionally, the firm also provides preclinical studies and drug development services.
Who invested in Calypso Biotech
5 investors across 3 rounds
See all investors in Calypso Biotech
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about Calypso Biotech
Who invested in Calypso Biotech?
Calypso Biotech has 5 investors on record across 3 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Calypso Biotech raised?
Calypso Biotech has raised 3 venture rounds. Sign up free to see how much each round raised and the total.
When did Calypso Biotech last raise money?
Calypso Biotech's most recent round on record is a Series A, in Sep 2021.
What does Calypso Biotech do?
Calypso Biotech is a biotechnology company.
Where is Calypso Biotech headquartered?
Calypso Biotech is headquartered in Plan-les-Ouates, Switzerland.
Which VCs invest in companies like Calypso Biotech?
Among active investors with capital left to deploy, Index Ventures, Forbion, European Investment Bank and Highland Europe back biotechnology companies at Calypso Biotech's stage. Their profiles are linked below.
VCs backing biotechnology startups at Series A
Raising like Calypso Biotech? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.